Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

William Zamboni

Univ of North Carolina Chapel Hill, Department: Pharmacology

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Glolytics, LLC

Disclosed Value
Listed Reason
Payment for services (e.g., consulting fees, honoraria, paid authorship)

The SFIs of the investigator are related to the funded research since the technology being used in the project has been licensed to the company with which the investigator has multiple relationships.

The Institution has determined that since the technology could be further validated as a result of the research, these financial interests could conflict with project.

Listed Research Project
Overcoming anti-PEG immunity to restore prolonged circulation and efficacy of PEGylated therapeutics

Narrative: Antibodies against polyethylene glycol (PEG), a polymer widely used to modify protein drugs and nanomedicine, can compromise the efficacy and safety of many clinically used therapeutics containing the PEG polymer. There is currently no effective and safe method that allows the use of PEGylated drugs in patients with substantial levels of PEG-binding antibodies. Here, we will carefully optimize and evaluate the infusion of free PEG as a strategy to block PEG-binding antibodies from binding to PEG-modified drugs. The findings from this proposal will enable development of strategies to overcome anti-PEG immunity.

Filed on June 21, 2018.

Tell us what you know about William Zamboni's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
William Zamboni Univ of North Carolina Chapel Hill Conflict of Interest Glolytics, LLC $0 - $4,999
William Zamboni Univ of North Carolina Chapel Hill Conflict of Interest Glolytics, LLC Value cannot be readily determined
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page